“5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) as a third-line chemotherapy treatment in metastatic gastric cancer, after failure of fluoropyrimidine, platinum, anthracycline, and taxane” (2018) Biomolecules and Biomedicine, 18(2), pp. 170–177. doi:10.17305/bjbms.2017.2258.